Past SHOW Events‎ > ‎

SHOW June 2012

posted Jun 11, 2012, 3:30 PM by Steven Munevar   [ updated Dec 27, 2012, 11:04 AM ]
Deconstructing the Drug Development Process: New Paradigms for Pharmaceutical Innovation

Keynote Speaker: Kenneth I Kaitin, Ph.D.
  • Professor and Director at the Tufts Center for the Study of Drug Development (CSDD), Tufts University School of Medicine
June’s SHOW focused on the drug development process and highlighted new paradigms for pharmaceutical innovation. In the current pharmaceutical research-based drug industry, the source of many of the medications in use today, economic, regulatory, and competitive pressures are forcing companies to re-evaluate and restructure their research and development (R&D) processes. The industry has been undergoing a transformation from fully-integrated pharmaceutical companies (FIPCos) to a network model (FIPNet) that encompasses all the major stakeholders in drug development including: large and small pharmaceutical and biotechnology companies, academic research institutions, patient groups, public-private-partnerships, and contract research organizations. Our special guest speaker Dr. Kenneth Kaitin discussed these and other major shifts within the pharmaceutical industry.

Dr. Kaitin is the Director of the Tufts Center for the Study of Drug Development (CSDD) which has been documenting the increasing challenge of bringing new medicines to market for over 35 years. Further, Dr. Kaitin is an internationally recognized expert on the science of drug development. He writes and speaks prolifically on factors that contribute to the slow pace and high cost of pharmaceutical R&D and the impact of efforts to speed the drug development process. Dr. Kaitin has also provided public testimony before the U.S. Congress on pharmaceutical development, regulation, and policy issues. He is a former President of the Drug Information Association, and is currently Editor-in-Chief of Expert Review of Clinical Pharmacology as well as serving on the boards of directors and scientific advisory boards of several public, private, and not-for-profit life sciences companies and organizations.

Science Shaping Our World-SHOW – Ongoing Seminar/Networking Series:
Deconstructing the Drug Development Process: New Paradigms for Pharmaceutical Innovation
Picture SHOW:


Event Hosted By
:

Comments